Our genetically engineered mouse model, or GEMM, team offers state-of-the-art services for the development and maintenance of transgenic mouse strains, including all modern genome editing tools and expertise in mouse transgenesis. We use CRISPR/Cas9 gene editing, which offers several advantages over traditional mouse transgenic technologies, including time savings, cost effectiveness and a potential reduction in animal usage. We continue to pursue new technologies and develop novel resources for preclinical research.
Our expert staff work with investigators from the first stages of experimental design through successful project completion.
To schedule services with the Preclinical Modeling shared resource, or to get more information about how we can work with you, contact the GEMM team lead:
Dr. Priti Singh
Director, GEMM Scientist